9
total announcements
531349.BO · 15 min delayed
Panacea Biotec Ltd
Panacea Biotec Ltd has announced a public notice requesting shareholders to register their email addresses with the company in connection with the upcoming 42nd Annual General Meeting.
Panacea Biotec Ltd
Panacea Biotec Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with total income at ₹1,59,687 lakhs, net profit for the period at ₹5,808 lakhs, and net profit for the period before tax at ₹6,058 lakhs.
Panacea Biotec Ltd
Panacea Biotec Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with a net profit of ₹139 crore and a total income from operations of ₹13,471 crore.
Panacea Biotec Ltd
Panacea Biotec Ltd has announced its standalone and consolidated unaudited financial results for the quarter ended June 30, 2026, with a net profit of Rs. 139 lakhs and a total income from operations of Rs. 13,471 lakhs.
Panacea Biotec Ltd
Panacea Biotec Ltd has announced the opening of a special window for transfer and dematerialization of physical shares, as per SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 dated January 30, 2026.
Panacea Biotec Ltd
Panacea Biotec Ltd has scheduled a Board Meeting on August 13, 2026, to consider and approve the Standalone and Consolidated Unaudited Financial Results (Provisional) for the quarter ended June 30, 2026.
Panacea Biotec Ltd
Panacea Biotec Ltd has informed the BSE that no shares were dematerialized during July 2026, and provided the total number of shares dematerialized as on July 31, 2026, as 6,11,05,526.
Panacea Biotec Ltd
Panacea Biotec Ltd has received a Letter of Award from UNICEF for the supply of bivalent Oral Polio Vaccine (bOPV) worth ~US$8.205 million in Calendar Year 2028.
Panacea Biotec Ltd
Panacea Biotec Ltd's wholly owned subsidiary, Panacea Biotec Pharma Ltd, has received a Show Cause Notice from the Assistant Commissioner, Goods and Services Tax, Delhi, alleging a tax liability of ₹4.06 Crore, including interest and penalty, on account of excess claim of Input Tax Credit in the Annual Return filed for the Financial Year 2022-23.